Zain Khalpey: The Hidden Impact of Sex Hormones on Thrombosis and Heart Health
Zain Khalpey, Adjunct Assistant Professor of Surgery at Columbia University Irving Medical Center, shared a post on LinkedIn about a recent article by Leslie Skeith et al, adding:
“This visual outlines how estrogen, progesterone, and testosterone affect coagulation pathways, platelet activity, red blood cells, and vascular function.
These physiologic changes can alter clotting risk depending on dose, formulation, and patient specific factors.
Recent evidence highlights the importance of evaluating individual risk, including prior thrombosis, underlying conditions, and treatment indication when considering hormone therapy.
Clear understanding of these mechanisms supports safer clinical decision making across cardiology, internal medicine, and women’s health.
Follow Zain Khalpey for more on AI and Healthcare.”
Title: Sex Hormone Influences on Venous Thrombotic and Cardiovascular Risk
Authors: Leslie Skeith, Shannon M. Bates
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 2, 2026, 18:26Strengthening Comprehensive Care for Inherited Bleeding Disorders in Ecuador – World Federation of Hemophilia
-
Sep 2, 2026, 18:24Zeeshan Ahmed Khattak: Managing Febrile Neutropenia in Hematology/Oncology and Transplant Patients
-
Sep 2, 2026, 18:22Mark Heyland: The Role of Thromboinflammation in Fracture Non-Union
-
Sep 2, 2026, 18:18Katie Gonzalez: Understanding the Hidden Risk of Inherited Thrombophilias
-
Sep 2, 2026, 18:14Beruni Narmada W: Rare Basal Vein of Rosenthal Thrombosis Presenting With Thalamic Haemorrhage
-
Sep 2, 2026, 18:03Omnia Ahmed: Effect of Hematocrit (HCT) on Coagulation Testing
-
Sep 2, 2026, 17:44John Thymis: Five E-Posters Presented at ESC Congress 2026 in Munich
-
Sep 2, 2026, 17:42Edward Lee Carter: In Antithrombotic Therapy, “More Protection” Can Become More Harm Surprisingly Quickly
-
Sep 2, 2026, 17:41Mohsin Raza: Why Is Anticoagulation Used During Hemodialysis?